Literature DB >> 21289330

Effects of therapeutic drug monitoring criteria in a computerized prescriber-order-entry system on the appropriateness of vancomycin level orders.

Kristi A Traugott1, Pamela R Maxwell, Kay Green, Christopher Frei, James S Lewis.   

Abstract

PURPOSE: The effects of therapeutic drug monitoring (TDM) criteria in a computerized prescriber-order-entry (CPOE) system on the appropriateness of orders for vancomycin levels were evaluated.
METHODS: Vancomycin TDM criteria were developed and implemented in a CPOE system. These criteria were displayed via a pop-up alert message when vancomycin levels were ordered and included directions for appropriate timing and justification for routine monitoring. Data for two groups of adult inpatients who had vancomycin levels ordered before and after criteria implementation were compared. Medical records were retrospectively reviewed for these patients to collect information regarding patient demographics, vancomycin dosage and indication, concurrent antibiotics and nephrotoxic agents during vancomycin therapy, length of stay, duration of vancomycin therapy, and number of vancomycin levels drawn. The primary outcome was the percent change in appropriate vancomycin levels ordered after criteria implementation.
RESULTS: A total of 200 patients were analyzed, 100 in each group. The percentage of appropriate orders for vancomycin levels significantly increased after criteria implementation (from 58% to 68%, p = 0.02). The greatest effect on appropriateness occurred with the first level ordered (52% versus 70% in the preimplementation and postimplementation groups, respectively; p = 0.01). The majority of inappropriate levels were due to improper timing of sample collections, accounting for 55% of the inappropriate levels evaluated.
CONCLUSION: A significant increase in the number of appropriately ordered and drawn serum vancomycin levels occurred after implementation of TDM criteria in the hospital's CPOE system. The majority of orders that were deemed inappropriate were due to improper timing of laboratory collection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289330     DOI: 10.2146/ajhp090661

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  9 in total

1.  Barriers and facilitators of appropriate vancomycin use: prescribing context is key.

Authors:  Joanne Oi Sze Chan; Melissa Therese Baysari; Jane Ellen Carland; Indy Sandaradura; Maria Moran; Richard Osborne Day
Journal:  Eur J Clin Pharmacol       Date:  2018-07-28       Impact factor: 2.953

2.  Evaluating incorporation of drug restrictions into computerized drug order entries after transition to an electronic health record.

Authors:  Ryan Rodriguez; Benjamin Staley; Randy C Hatton
Journal:  Hosp Pharm       Date:  2013-07

3.  Appropriateness of vancomycin therapeutic drug monitoring and its outcomes among non-dialysis patients in a tertiary hospital in Singapore.

Authors:  Jun Jie Benjamin Seng; Mei Hui Amanda Yong; Zi Xin Peh; Jie Lin Soong; Mooi Heong Tan
Journal:  Int J Clin Pharm       Date:  2018-06-12

4.  Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.

Authors:  K de With; F Allerberger; S Amann; P Apfalter; H-R Brodt; T Eckmanns; M Fellhauer; H K Geiss; O Janata; R Krause; S Lemmen; E Meyer; H Mittermayer; U Porsche; E Presterl; S Reuter; B Sinha; R Strauß; A Wechsler-Fördös; C Wenisch; W V Kern
Journal:  Infection       Date:  2016-06       Impact factor: 3.553

5.  Vancomycin dosing and therapeutic drug monitoring practices: guidelines versus real-life.

Authors:  Tatjana Van Der Heggen; Franky M Buyle; Barbara Claus; Annemie Somers; Petra Schelstraete; Peter De Paepe; Sophie Vanhaesebrouck; Pieter A J G De Cock
Journal:  Int J Clin Pharm       Date:  2021-04-28

6.  Uncovering Discrepancies in IV Vancomycin Infusion Records between Pump Logs and EHR Documentation.

Authors:  Tsan-Hua Tung; Poching DeLaurentis; Yuehwern Yih
Journal:  Appl Clin Inform       Date:  2022-09-21       Impact factor: 2.762

7.  Optimization of time to initial vancomycin target trough improves clinical outcomes.

Authors:  Anthony P Cardile; Christopher Tan; Michael B Lustik; Amy N Stratton; Cristian S Madar; Jun Elegino; Günther Hsue
Journal:  Springerplus       Date:  2015-07-19

8.  Assessment of vancomycin utilization among Lebanese hospitals.

Authors:  Diana N Malaeb; Iqbal M Fahs; Pascale Salameh; Souheil Hallit; Manal Saad; Jassem Bourji; Rabih Hallit
Journal:  Saudi Med J       Date:  2019-02       Impact factor: 1.484

9.  Early Vancomycin Concentrations and the Applications of a Pharmacokinetic Extrapolation Method to Recognize Sub-Therapeutic Outcomes.

Authors:  Oscar Santalo; Umima Baig; Mara Poulakos; Daniel Brown
Journal:  Pharmacy (Basel)       Date:  2016-11-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.